AstraZeneca reported 73.64B in Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Amgen AMGN:US $ 59773M 2766M
AstraZeneca AZN:LN 73641M 8715M
Astrazeneca AZN:US $ 73641M 8715M
AstraZeneca AZN:SS SK 73641M 8715M
Bayer BAYN:GR € 114427M 4350M
Biogen BIIB:US $ 24470.4M 615.7M
Bristol Myers Squibb BMY:US $ 110797M 1638M
Eli Lilly And LLY:US $ 47809M 970.7M
Fresenius FRE:GR € 69655M 689M
Fresenius Medical Care FME:GR € 32987M 172M
Galapagos GLPG:NA € 5430.62M 184.44M
Genmab GEN:DC DK 22483M 273M
Gilead Sciences GILD:US $ 67984M 492M
GlaxoSmithKline GSK:LN 77011M 1068M
GRIFOLS GRF:SM € 16213.05M 75.45M
H. Lundbeck A/S LUN:DC 34.04B 429M
Hikma Pharmaceutical HIK:LN 4.18B 45M
Lonza Group LONN:SW 15.16B 732M
Merck MRK:GR € 43145M 746M
Novartis NOVN:VX SF 124015M 2263M
Orion ORNBV:FH € 1041.4M 144.2M
Recordati REC:IM € 2875.92M 38.45M
Regeneron Pharmaceuticals REGN:US $ 21485.9M 3713.7M